Novartis AG (ADR)

General ticker "NVS" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $216.7B (TTM average)

Novartis AG (ADR) does not follow the US Stock Market performance with the rate: -0.8%.

Estimated limits based on current volatility of 1.0%: low 108.10$, high 110.34$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-03-12, amount 3.99$ (Y3.66%)
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [69.99$, 110.57$]
  • 2025-12-31 to 2026-12-31 estimated range: [66.17$, 105.90$]

Financial Metrics affecting the NVS estimates:

  • Positive: Non-GAAP EPS, $ of 7.81 > 2.19
  • Positive: 22.52 < Shareholder equity ratio, % of 43.08 <= 43.26
  • Positive: Operating profit margin, % of 28.12 > 18.46
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: 0.10 < Interest expense per share, $ of 0.50
  • Negative: Industry operating cash flow per share per price (median), % of -8.00 <= 2.82
  • Positive: Return on assets ratio (scaled to [-100,100]) of 10.46 > 6.86

Similar symbols

Short-term NVS quotes

2025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-092025-05-1298100102104106108110112114
Price $

Long-term NVS plot with estimates

708090100110120130140150Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 202700.511.52
NVSS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $51,828.00MM $46,660.00MM $51,722.00MM
Operating Expenses $42,631.00MM $36,891.00MM $37,178.00MM
Operating Income $9,197.00MM $9,769.00MM $14,544.00MM
Non-Operating Income $-826.00MM $-646.00MM $-904.00MM
Interest Expense $837.00MM $855.00MM $1,006.00MM
R&D Expense $9,996.00MM $11,371.00MM $10,022.00MM
Income(Loss) $8,371.00MM $9,123.00MM $13,640.00MM
Taxes $1,416.00MM $551.00MM $1,701.00MM
Profit(Loss)* $6,955.00MM $14,850.00MM $11,941.00MM
Stockholders Equity $59,342.00MM $46,667.00MM $44,046.00MM
Inventory $7,175.00MM $5,913.00MM $5,723.00MM
Assets $117,453.00MM $99,945.00MM $102,246.00MM
Operating Cash Flow $14,236.00MM $14,458.00MM $17,619.00MM
Capital expenditure $2,671.00MM $2,753.00MM $3,814.00MM
Investing Cash Flow $1,468.00MM $5,596.00MM $-7,513.00MM
Financing Cash Flow $-20,562.00MM $-14,278.00MM $-11,742.00MM
Earnings Per Share** $3.19 $7.15 $5.92
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.